Annovis Bio ANVS Income Statement (2019-2026)

NYSE ANVS
$1.79 -0.06 (-3.24%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
8.09M8.10M8.10M8.16M8.16M8.16M8.16M8.22M9.01M9.01M10.52M11.01M11.72M13.28M14.14M19.49M19.49M20.19M20.55M28.54M
Operating items
Research & Development (Quarter)
1.82M1.38M2.88M2.15M4.03M4.12M6.21M7.79M8.26M13.84M8.90M6.51M5.79M2.69M5.00M5.01M5.16M6.29M8.75M16.72M
Wages, Salaries and Other (Quarter)
1.19M2.33M1.13M1.89M1.40M1.50M1.22M0.74M1.27M
Selling, General & Administrative (Quarter)
0.71M1.47M3.04M3.10M1.94M2.36M1.59M2.18M1.50M1.03M1.54M1.29M1.98M1.70M1.74M1.27M1.11M1.14M0.96M1.29M
Operating Expenses (Quarter)
2.53M2.85M5.92M5.25M5.97M6.48M7.80M9.97M9.76M14.86M10.44M7.81M7.76M4.39M6.73M6.28M6.27M7.43M9.71M18.01M
Operating Income (Quarter)
-2.53M-2.85M-5.92M-5.25M-5.97M-6.48M-7.80M-9.97M-9.76M-14.86M-10.44M-7.80M-7.76M-4.39M-6.74M-6.30M-6.27M-7.43M-9.71M-18.00M
EBIT (Quarter)
-2.53M-2.85M-5.92M-5.25M-5.97M-6.48M-7.80M-9.97M-9.76M-14.86M-10.44M-7.80M-7.76M-4.39M-6.74M-6.30M-6.27M-7.43M-9.71M-18.00M
Non-operating items
Interest & Investment Income (Quarter)
0.15M0.07M0.04M0.03M0.14M0.13M0.19M0.19M0.15M0.17M0.14M
Other Non Operating Income (Quarter)
0.01M6.70M2.72M-8.39M0.74M0.56M-0.14M0.02M-0.30M0.27M
Non Operating Income (Quarter)
0.01M0.01M0.01M0.02M0.04M0.05M0.07M0.23M0.22M0.15M-11.77M6.74M2.74M-8.25M0.87M0.75M0.05M0.17M-0.13M0.41M
Net income details
EBT (Quarter)
-2.52M-2.85M-5.91M-5.23M-5.94M-6.43M-7.73M-9.74M-9.54M-14.72M-22.21M-1.07M-5.02M-12.64M-7.91M-6.11M-6.35M-7.53M-10.32M-18.12M
Profit After Tax (Quarter)
-2.52M-2.85M-5.93M-5.23M-5.94M-6.43M-7.70M-9.74M-9.54M-14.72M-22.21M-1.07M-5.02M-12.64M-5.89M-5.54M-6.22M-7.26M-9.88M-17.60M
Income from Continuing Operations (Quarter)
-2.52M-2.85M-5.91M-5.23M-5.94M-6.43M-7.73M-9.74M-9.54M-14.72M-22.21M-1.07M-5.02M-12.64M-7.91M-6.11M-6.35M-7.53M-10.32M-18.12M
Consolidated Net Income (Quarter)
-2.52M-2.85M-5.91M-5.23M-5.94M-6.43M-7.73M-9.74M-9.54M-14.72M-22.21M-1.07M-5.02M-12.64M-7.91M-6.11M-6.35M-7.53M-10.32M-18.12M
Income towards Parent Company (Quarter)
-2.52M-2.85M-5.91M-5.23M-5.94M-6.43M-7.73M-9.74M-9.54M-14.72M-22.21M-1.07M-5.02M-12.64M-7.91M-6.11M-6.35M-7.53M-10.32M-18.12M
Net Income towards Common Stockholders (Quarter)
-2.52M-2.85M-5.91M-5.23M-5.94M-6.43M-7.73M-9.74M-9.54M-14.72M-22.21M-1.07M-5.02M-12.64M-7.91M-6.11M-6.35M-7.53M-10.32M-18.12M
Additional items
EPS (Basic) (Quarter)
-0.34-0.35-0.78-0.64-0.73-0.79-0.95-1.19-1.07-1.63-2.46-0.10-0.44-0.97-0.65-0.35-0.33-0.38-0.50-0.65
EPS (Diluted) (Quarter)
-0.34-0.35-0.78-0.64-0.73-0.79-0.95-1.19-1.07-1.63-2.46-0.10-0.44-0.97-0.65-0.35-0.33-0.38-0.50-0.65
Shares Outstanding (Quarter)
7.37M8.10M7.63M8.16M8.16M8.16M8.16M8.19M8.95M9.01M9.02M10.63M11.31M12.98M12.18M17.43M19.49M19.69M20.55M27.85M
Shares Outstanding (Diluted) (Quarter)
7.37M8.10M7.63M8.16M8.16M8.16M8.16M8.19M8.95M9.01M9.02M10.82M11.31M12.98M12.24M17.43M19.49M19.69M20.55M27.85M
EBITDA (Quarter)
-2.53M-2.85M-5.92M-5.25M-5.97M-6.48M-7.80M-9.97M-9.76M-14.86M-10.44M-7.80M-7.76M-4.39M-6.74M-6.30M-6.27M-7.43M-9.71M-18.00M
Interest Expenses (Quarter)
10.92M18.48M17.86M1.30M0.27M0.24M0.78M0.26M